Recursion Pharmaceuticals Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Recursion Pharmaceuticals's estimated annual revenue is currently $44.8M per year.
- Recursion Pharmaceuticals received $20.5M in venture funding in June 2018.
- Recursion Pharmaceuticals's estimated revenue per employee is $201,000
- Recursion Pharmaceuticals's total funding is $465.4M.
- Recursion Pharmaceuticals has 223 Employees.
- Recursion Pharmaceuticals grew their employee count by 26% last year.
- Recursion Pharmaceuticals currently has 11 job openings.
What Is Recursion Pharmaceuticals?
Recursion Pharmaceuticals has developed a powerful drug discovery platform involving millions of rapid, automated experiments and analysis to discover new therapeutics. Our platform has resulted in the massive parallelization of drug discovery. We have deployed this platform in pursuit of drugs for the treatment of rare genetic diseases. We partner or out-license these leads to major pharmaceutical companies early in development. Our horizontal business model focused on discovery accelerates our impact and reduces our costs by avoiding slow and costly in-house development, and allows us to spread risk across many new therapeutic opportunities.keywords:Biotechnology,Healthcare,Pharmaceuticals